Drug Pricing and Regulation
Economic Markets and Pharmaceutical Innovation
(pp. 3–26)
Patents, Innovation, and Competition in Pharmaceuticals: The Hatch-Waxman Act after 40 Years
(pp. 27–52)
Lessons for the United States from Pharmaceutical Regulation Abroad
(pp. 53–78)
The Economics of Generic Drug Shortages: The Limits of Competition
(pp. 79–102)